About this Research Topic
Nanomaterials in photothermal agents have emerged as a hot trend in the field of biomaterial research in recent years. Although they are still at the initial research stage, researchers are gradually furthering our understanding of nanobiomedical materials. Indeed, the development of biomedical nanomaterials has evolved from initial synthesis to the current design of function.
Cancer and cardiovascular diseases are both serious conditions that challenge the health and survival of people across the world. Photothermal therapy, as a minimally invasive and local treatment modality, avoids the issue of multidrug resistance among patients, as well as collateral damage to healthy cells and tissues that can result from traditional therapies. It therefore shows promise as an alternative treatment approach. The past few decades have witnessed great efforts dedicated to the synthesis and development of photothermal nanomaterials, which are drawing widespread attention due to their unique features such as low cost, facile synthesis, high photothermal conversion efficiency, good photostability, and fine-tuned absorption spectrum. Recent progress in the synthesis of these types of nanomaterials has mainly concentrated on nanocomposites with synergistic effects, which requires complicated synthesis processes. The design and synthesis of such an effective platform with controllable properties remains a challenge.
This Research Topic aims to provide a forum for the exchange of clinical and scientific information for the design and synthesis of photothermal agents involved in efforts to integrate imaging and photothermal therapy of cancer and cardiovascular diseases. Submissions relating to the fields of facile synthesis and bioapplication of multifunctional photothermal agents, design and bioapplication of photothermal agents with controllable properties, and in vivo image-guided photothermal therapy of cancer and cardiovascular diseases are particularly welcomed. We welcome both original research and review articles that further our understanding and bridge the gap between laboratory, clinic, and the biotechnology industries.
Potential topics include but are not limited to the following:
Facile synthesis and bioapplication of multifunctional photothermal nanomaterials for cancer and cardiovascular diseases
• By means of simple synthesis methods (e.g. hydrothermal, self-assembly), photothermal nanomaterials with imaging and photothermal conversion performance are achievable. Their function is then verified through in vivo animal experiments.
Design and bioapplication of photothermal agents with controllable properties for cancer and cardiovascular diseases
• Photothermal agents with controllable composition, morphology, crystal phase, and other properties can be obtained. These photothermal agents can be used for the efficient photothermal therapy of cancer and cardiovascular diseases.
Image-guided photothermal therapy of cancer and cardiovascular diseases
• Photothermal nanomaterials are synthesized by simple methods and systematically characterized, and finally applied to in vivo imaging and treatment of cancer and cardiovascular diseases.
Cancer and cardiovascular diseases are both serious conditions that challenge the health and survival of people across the world. Photothermal therapy, as a minimally invasive and local treatment modality, avoids the issue of multidrug resistance among patients, as well as collateral damage to healthy cells and tissues that can result from traditional therapies. It therefore shows promise as an alternative treatment approach. The past few decades have witnessed great efforts dedicated to the synthesis and development of photothermal nanomaterials, which are drawing widespread attention due to their unique features such as low cost, facile synthesis, high photothermal conversion efficiency, good photostability, and fine-tuned absorption spectrum. Recent progress in the synthesis of these types of nanomaterials has mainly concentrated on nanocomposites with synergistic effects, which requires complicated synthesis processes. The design and synthesis of such an effective platform with controllable properties remains a challenge.
This Research Topic aims to provide a forum for the exchange of clinical and scientific information for the design and synthesis of photothermal agents involved in efforts to integrate imaging and photothermal therapy of cancer and cardiovascular diseases. Submissions relating to the fields of facile synthesis and bioapplication of multifunctional photothermal agents, design and bioapplication of photothermal agents with controllable properties, and in vivo image-guided photothermal therapy of cancer and cardiovascular diseases are particularly welcomed. We welcome both original research and review articles that further our understanding and bridge the gap between laboratory, clinic, and the biotechnology industries.
Potential topics include but are not limited to the following:
Facile synthesis and bioapplication of multifunctional photothermal nanomaterials for cancer and cardiovascular diseases
• By means of simple synthesis methods (e.g. hydrothermal, self-assembly), photothermal nanomaterials with imaging and photothermal conversion performance are achievable. Their function is then verified through in vivo animal experiments.
Design and bioapplication of photothermal agents with controllable properties for cancer and cardiovascular diseases
• Photothermal agents with controllable composition, morphology, crystal phase, and other properties can be obtained. These photothermal agents can be used for the efficient photothermal therapy of cancer and cardiovascular diseases.
Image-guided photothermal therapy of cancer and cardiovascular diseases
• Photothermal nanomaterials are synthesized by simple methods and systematically characterized, and finally applied to in vivo imaging and treatment of cancer and cardiovascular diseases.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
